Search

Your search keyword '"Nakajima, Shigeru"' showing total 292 results

Search Constraints

Start Over You searched for: Author "Nakajima, Shigeru" Remove constraint Author: "Nakajima, Shigeru"
292 results on '"Nakajima, Shigeru"'

Search Results

8. Effect of CVD-SiO(sub 2) film on reliability of GaAs MESFET with Ti/Pt/Au gate metal

13. On the frequency dependent drain conductance of ion-implanted GaAs MESFETs

14. Influence of Timing of Insulin Initiation on Long-term Glycemic Control in Japanese Patients with Type 2 Diabetes: A Retrospective Cohort Study

18. Enhancement-mode GaAs MESFET technology for low consumption power and low noise applications

19. Low-noise characteristics of pulse-doped GaAs MESFET's with planar self-aligned gates

21. Sitagliptin Versus Ipragliflozin for Type 2 Diabetes in Clinical Practice

22. Efficacy and Safety of Ipragliflozin in Patients With Type 2 Diabetes: ASSIGN-K Study

23. Efficacy and Safety of Adding Sitagliptin in Type 2 Diabetes Patients on Insulin: Age-Stratified Comparison at One Year in the ASSIST-K Study

31. Association of usual sleep quality and glycemic control in type 2 diabetes in Japanese: A cross sectional study. Sleep and Food Registry in Kanagawa (SOREKA)

33. Add-On Sitagliptin Therapy for Insulin-Treated Type 2 Diabetes: An Analysis of Hemoglobin A1c and Other Variables Using ASSIST-K Follow-Up Data

37. Effectiveness of Ipragliflozin for Reducing Hemoglobin A1c in Patients With a Shorter Type 2 Diabetes Duration: Interim Report of the ASSIGN-K Study

39. Effect of Switching From an Anti-Diabetic Loose Dose Combination to a Fixed Dose Combination Regimen at Equivalent Dosage for 6 Months on Glycemic Control in Japanese Patients With Type 2 Diabetes: A Pilot Study

40. Ipragliflozin Improves Glycemic Control and Decreases Body Fat in Patients With Type 2 Diabetes Mellitus

42. Correction: Efficacy and Safety of Ipragliflozin in Japanese Patients With Type 2 Diabetes: Interim Outcome of the ASSIGN-K Study

44. Efficacy and Safety of Ipragliflozin in Japanese Patients With Type 2 Diabetes: Interim Outcome of the ASSIGN-K Study

45. Factors Influencing Changes in Hemoglobin A1c and Body Weight During Treatment of Type 2 Diabetes With Ipragliflozin: Interim Analysis of the ASSIGN-K Study

46. Inhibition of growth of human tumor cells in nude mice by a metalloproteinase inhibitor

49. Factors Predicting Therapeutic Efficacy of Combination Treatment With Sitagliptin and Insulin in Type 2 Diabetic Patients: The ASSIST-K Study

Catalog

Books, media, physical & digital resources